Patterns and influences in health-related quality of life in children with immune thrombocytopenia

A study from the Dallas ITP Cohort

Adolfo Flores, Robert J. Klaassen, George R. Buchanan, Cindy E Neunert

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Relationships between clinical/demographic factors and health-related quality of life (HRQoL) in childhood immune thrombocytopenia (ITP) remain poorly understood. Recent studies reveal conflicting information about factors that contribute to HRQoL. Methods: This was a prospective, single-institution, cohort study of newly diagnosed children with ITP. Serial evaluations of HRQoL were performed using the Kid's ITP Tools (KIT), scored from 0 (worst) to 100 (best), at enrollment and 1 week, 6 months, and 12 months following diagnosis. All visits included bleeding severity grading. Relationships between HRQoL and platelet count, treatment, bleeding severity, and course of disease were examined. Results: A total of 99 children with newly diagnosed ITP were evaluable for analysis. KIT scores were low at diagnosis for parents (median 26, range 15–43) and children (median 65, range 55–81) and were not influenced by age or platelet count. At diagnosis, children who received treatment had lower platelet counts (P = 0.005), more severe hemorrhage (P < 0.0125), and lower HRQoL by parent, child, and proxy reporting (P < 0.05). Oral bleeding negatively impacted proxy-reported disease burden at diagnosis (P = 0.01). Persistence of disease and lower platelet counts at 6 and 12 month visits were the only factors noted to consistently impact quality of life beyond diagnosis for both parents and children. Conclusions: HRQoL is low at diagnosis but significantly improves over time. Patients with ongoing disease and lower platelet counts continue to have significant disease burden.

Original languageEnglish (US)
Article numbere26405
JournalPediatric Blood and Cancer
Volume64
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Idiopathic Thrombocytopenic Purpura
Quality of Life
Platelet Count
Hemorrhage
Proxy
Parents
Inosine Triphosphate
Cohort Studies
Demography
Therapeutics

Keywords

  • bleeding severity
  • childhood ITP
  • health-related quality of life

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Patterns and influences in health-related quality of life in children with immune thrombocytopenia : A study from the Dallas ITP Cohort. / Flores, Adolfo; Klaassen, Robert J.; Buchanan, George R.; Neunert, Cindy E.

In: Pediatric Blood and Cancer, Vol. 64, No. 8, e26405, 01.08.2017.

Research output: Contribution to journalArticle

Flores, Adolfo ; Klaassen, Robert J. ; Buchanan, George R. ; Neunert, Cindy E. / Patterns and influences in health-related quality of life in children with immune thrombocytopenia : A study from the Dallas ITP Cohort. In: Pediatric Blood and Cancer. 2017 ; Vol. 64, No. 8.
@article{c04f8df86cdb49619dcac03b0d723e58,
title = "Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort",
abstract = "Background: Relationships between clinical/demographic factors and health-related quality of life (HRQoL) in childhood immune thrombocytopenia (ITP) remain poorly understood. Recent studies reveal conflicting information about factors that contribute to HRQoL. Methods: This was a prospective, single-institution, cohort study of newly diagnosed children with ITP. Serial evaluations of HRQoL were performed using the Kid's ITP Tools (KIT), scored from 0 (worst) to 100 (best), at enrollment and 1 week, 6 months, and 12 months following diagnosis. All visits included bleeding severity grading. Relationships between HRQoL and platelet count, treatment, bleeding severity, and course of disease were examined. Results: A total of 99 children with newly diagnosed ITP were evaluable for analysis. KIT scores were low at diagnosis for parents (median 26, range 15–43) and children (median 65, range 55–81) and were not influenced by age or platelet count. At diagnosis, children who received treatment had lower platelet counts (P = 0.005), more severe hemorrhage (P < 0.0125), and lower HRQoL by parent, child, and proxy reporting (P < 0.05). Oral bleeding negatively impacted proxy-reported disease burden at diagnosis (P = 0.01). Persistence of disease and lower platelet counts at 6 and 12 month visits were the only factors noted to consistently impact quality of life beyond diagnosis for both parents and children. Conclusions: HRQoL is low at diagnosis but significantly improves over time. Patients with ongoing disease and lower platelet counts continue to have significant disease burden.",
keywords = "bleeding severity, childhood ITP, health-related quality of life",
author = "Adolfo Flores and Klaassen, {Robert J.} and Buchanan, {George R.} and Neunert, {Cindy E}",
year = "2017",
month = "8",
day = "1",
doi = "10.1002/pbc.26405",
language = "English (US)",
volume = "64",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Patterns and influences in health-related quality of life in children with immune thrombocytopenia

T2 - A study from the Dallas ITP Cohort

AU - Flores, Adolfo

AU - Klaassen, Robert J.

AU - Buchanan, George R.

AU - Neunert, Cindy E

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Background: Relationships between clinical/demographic factors and health-related quality of life (HRQoL) in childhood immune thrombocytopenia (ITP) remain poorly understood. Recent studies reveal conflicting information about factors that contribute to HRQoL. Methods: This was a prospective, single-institution, cohort study of newly diagnosed children with ITP. Serial evaluations of HRQoL were performed using the Kid's ITP Tools (KIT), scored from 0 (worst) to 100 (best), at enrollment and 1 week, 6 months, and 12 months following diagnosis. All visits included bleeding severity grading. Relationships between HRQoL and platelet count, treatment, bleeding severity, and course of disease were examined. Results: A total of 99 children with newly diagnosed ITP were evaluable for analysis. KIT scores were low at diagnosis for parents (median 26, range 15–43) and children (median 65, range 55–81) and were not influenced by age or platelet count. At diagnosis, children who received treatment had lower platelet counts (P = 0.005), more severe hemorrhage (P < 0.0125), and lower HRQoL by parent, child, and proxy reporting (P < 0.05). Oral bleeding negatively impacted proxy-reported disease burden at diagnosis (P = 0.01). Persistence of disease and lower platelet counts at 6 and 12 month visits were the only factors noted to consistently impact quality of life beyond diagnosis for both parents and children. Conclusions: HRQoL is low at diagnosis but significantly improves over time. Patients with ongoing disease and lower platelet counts continue to have significant disease burden.

AB - Background: Relationships between clinical/demographic factors and health-related quality of life (HRQoL) in childhood immune thrombocytopenia (ITP) remain poorly understood. Recent studies reveal conflicting information about factors that contribute to HRQoL. Methods: This was a prospective, single-institution, cohort study of newly diagnosed children with ITP. Serial evaluations of HRQoL were performed using the Kid's ITP Tools (KIT), scored from 0 (worst) to 100 (best), at enrollment and 1 week, 6 months, and 12 months following diagnosis. All visits included bleeding severity grading. Relationships between HRQoL and platelet count, treatment, bleeding severity, and course of disease were examined. Results: A total of 99 children with newly diagnosed ITP were evaluable for analysis. KIT scores were low at diagnosis for parents (median 26, range 15–43) and children (median 65, range 55–81) and were not influenced by age or platelet count. At diagnosis, children who received treatment had lower platelet counts (P = 0.005), more severe hemorrhage (P < 0.0125), and lower HRQoL by parent, child, and proxy reporting (P < 0.05). Oral bleeding negatively impacted proxy-reported disease burden at diagnosis (P = 0.01). Persistence of disease and lower platelet counts at 6 and 12 month visits were the only factors noted to consistently impact quality of life beyond diagnosis for both parents and children. Conclusions: HRQoL is low at diagnosis but significantly improves over time. Patients with ongoing disease and lower platelet counts continue to have significant disease burden.

KW - bleeding severity

KW - childhood ITP

KW - health-related quality of life

UR - http://www.scopus.com/inward/record.url?scp=85020685723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020685723&partnerID=8YFLogxK

U2 - 10.1002/pbc.26405

DO - 10.1002/pbc.26405

M3 - Article

VL - 64

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 8

M1 - e26405

ER -